Position in ABUS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$132,172
-$5,307 QoQ
Shares Held
27,536
-9.9% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#108
of 175 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. ABUS ranks #126 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in ABUS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $132,172 | 27,536 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $137,479 | 30,551 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $173,934 | 36,161 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $148,526 | 32,715 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $118,022 | 38,195 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $140,200 | 40,172 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $163,895 | 50,121 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $149,233 | 38,762 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $88,429 | 28,618 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $89,048 | 34,515 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $79,215 | 31,686 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $55,155 | 27,170 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $62,058 | 26,982 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $73,383 | 24,219 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $64,210 | 27,558 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $46,823 | 24,515 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $64,262 | 23,713 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $92,618 | 31,080 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $142,370 | 36,599 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $135,036 | 31,477 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $113,867 | 37,580 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $39,127 | 11,750 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $46,519 | 13,104 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||